Recurrent Small Lymphocytic Lymphoma Clinical Trials

Completed

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

NCT00789776

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States

Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

NCT00040846

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Completed

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

NCT00005803

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +33 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

NCT00089011

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

NCT00014235

Conditions: Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
Locations: University of Arizona Health Sciences Center Tucson, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Stanford University Hospitals and Clinics Stanford, California, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

NCT00006251

Conditions: Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

NCT00078858

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
Locations: Stanford University Hospitals and Clinics Stanford, California, United States

Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions: Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

NCT00003196

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
Locations: City of Hope Medical Center Duarte, California, United States

Stanford University Hospitals and Clinics Stanford, California, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

Universitaet Leipzig Leipzig, Germany

View Trial Details

Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

NCT00723099

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Recurrent Small Lymphocytic Lymphoma

Recurrent Small Lymphocytic Lymphoma trial results

Related conditions